Peptide library › Hormonal & fertility
Octreotide
Also known as Sandostatin, Sandostatin LAR, Mycapssa
Long-lasting copy of somatostatin that switches off excess growth hormone and gut hormones; used for acromegaly and hormone-producing tumours.
What people use it for
- Acromegaly
- Symptoms of neuroendocrine tumours, such as flushing and diarrhoea
- Bleeding from swollen veins in the gullet (hospital use)
What Octreotide does in the body
Mimics somatostatin, the body's 'off switch' for many hormones, including growth hormone, insulin, glucagon and gut hormones. It lasts far longer than natural somatostatin.
Strength of evidence
Strong: established for decades.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Diarrhoea, stomach cramps and wind
- Gallstones with long-term use
- Changes in blood sugar
- Slow heart rate
Who should avoid it or take extra care
- Gallbladder disease needs monitoring
- Pregnancy or breastfeeding, unless a specialist advises it
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 1988, with a monthly depot later and an oral capsule (Mycapssa) in 2020. Prescription only.
How it's taken
Route: Injection under the skin, monthly depot into a muscle, or capsules
How long it lasts (half-life): About 1.5 to 2 hours; the depot lasts about 4 weeks
Storage
Ampoules refrigerated; the depot kit is refrigerated before use.
Latest research & news
- Statement of Retraction: Octreotide activates autophagy to alleviate lipopolysaccharide-induced human pulmonary epithelial cell injury by inhibiting the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway
Research · Study · PubMed · Bioengineered · 21 Nov 2026 - Mineralocorticoid receptor signaling reduces somatostatin expression in developing sensory neurons and drives neonatal pain after early-life stress
Research · Study · PubMed · Pain · 21 Nov 2026 - Application of 18F-SSTR2 Antagonist PET/CT in Neuroendocrine Tumors
Clinical trial · Recruiting · Updated · ClinicalTrials.gov · 19 Nov 2026 - Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Clinical trial · Active not recruiting · Phase 3 · Results posted · Updated · ClinicalTrials.gov · 18 Nov 2026 - Long-term outcome of dietary therapy in primary intestinal lymphangiectasia: Are we achieving sustained remission? A national retrospective study
Research · Study · PubMed · J Pediatr Gastroenterol Nutr · 18 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Octreotide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Octreotide in Fiala How to installMore in Hormonal & fertility
- Kisspeptin-10Short form of kisspeptin, the hormone that switches on the reproductive axis.
- GonadorelinSynthetic version of gonadotropin-releasing hormone (GnRH).
- OxytocinNatural hormone that drives labor and milk let-down, also studied for social bonding.
- CetrorelixFertility-treatment injection that stops early ovulation while the ovaries are being stimulated for IVF.
- GanirelixDaily IVF injection that blocks early ovulation during ovarian stimulation, similar to cetrorelix.
- GoserelinSmall implant placed under the skin every 1 or 3 months to shut down sex hormones, mainly for prostate and breast cancer.
- HistrelinYear-long implant that pauses early puberty in children by shutting down sex-hormone signals.
- LeuprolideWidely used hormone-blocking injection for prostate cancer, endometriosis, fibroids and early puberty.
- NafarelinHormone-suppressing nasal spray for endometriosis and early puberty.
- TriptorelinLong-acting hormone-blocking injection for prostate cancer and early puberty.
- Human chorionic gonadotropinPregnancy hormone used as a prescription medicine to trigger ovulation and to treat low testosterone from pituitary problems.
- CorticotropinLong-acting gel form of ACTH, the hormone that tells the adrenal glands to make cortisol; used for infantile spasms and some inflammatory conditions.
- CosyntropinShort version of ACTH used in a one-off test to check whether the adrenal glands make enough cortisol.
- LanreotideMonthly somatostatin-like injection for acromegaly and neuroendocrine tumours.
- PasireotideSomatostatin-like medicine for Cushing's disease and acromegaly when surgery hasn't worked.